ACYLSULFONAMIDE DERIVATIVE
PROBLEM TO BE SOLVED: To provide an ACC (acetyl-CoA carboxylase) activity inhibitor effective for treatment of hyperlipemia induced by obesity and fatness, abnormal glucose tolerance, diabetes, diabetic complications, hypertension and arteriosclerosis considered to be based on fatty liver and insuli...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MAEZONO KATSUMI KONDO NOBUO NIHEI YUKIO SUZUKI NOBUYASU ICHINOSE HIDEHIRO YAMAMOTO TAKASHI NAKANISHI EIJI HATANAKA TOSHIHIRO OSUMI KOJI |
| description | PROBLEM TO BE SOLVED: To provide an ACC (acetyl-CoA carboxylase) activity inhibitor effective for treatment of hyperlipemia induced by obesity and fatness, abnormal glucose tolerance, diabetes, diabetic complications, hypertension and arteriosclerosis considered to be based on fatty liver and insulin tolerance. SOLUTION: An acylsulfonamide derivative represented by general formula (1), its analogue or its pharmaceutically acceptable salt has effective inhibitory actions on the ACC activity. COPYRIGHT: (C)2005,JPO&NCIPI |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2005162612A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2005162612A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2005162612A3</originalsourceid><addsrcrecordid>eNrjZJBydI70CQ71cfP3c_T1dHFVcHEN8gxzDPEMc-VhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGBqaGZkZmhkaOxkQpAgCG3CDa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ACYLSULFONAMIDE DERIVATIVE</title><source>esp@cenet</source><creator>MAEZONO KATSUMI ; KONDO NOBUO ; NIHEI YUKIO ; SUZUKI NOBUYASU ; ICHINOSE HIDEHIRO ; YAMAMOTO TAKASHI ; NAKANISHI EIJI ; HATANAKA TOSHIHIRO ; OSUMI KOJI</creator><creatorcontrib>MAEZONO KATSUMI ; KONDO NOBUO ; NIHEI YUKIO ; SUZUKI NOBUYASU ; ICHINOSE HIDEHIRO ; YAMAMOTO TAKASHI ; NAKANISHI EIJI ; HATANAKA TOSHIHIRO ; OSUMI KOJI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide an ACC (acetyl-CoA carboxylase) activity inhibitor effective for treatment of hyperlipemia induced by obesity and fatness, abnormal glucose tolerance, diabetes, diabetic complications, hypertension and arteriosclerosis considered to be based on fatty liver and insulin tolerance. SOLUTION: An acylsulfonamide derivative represented by general formula (1), its analogue or its pharmaceutically acceptable salt has effective inhibitory actions on the ACC activity. COPYRIGHT: (C)2005,JPO&NCIPI</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050623&DB=EPODOC&CC=JP&NR=2005162612A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050623&DB=EPODOC&CC=JP&NR=2005162612A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MAEZONO KATSUMI</creatorcontrib><creatorcontrib>KONDO NOBUO</creatorcontrib><creatorcontrib>NIHEI YUKIO</creatorcontrib><creatorcontrib>SUZUKI NOBUYASU</creatorcontrib><creatorcontrib>ICHINOSE HIDEHIRO</creatorcontrib><creatorcontrib>YAMAMOTO TAKASHI</creatorcontrib><creatorcontrib>NAKANISHI EIJI</creatorcontrib><creatorcontrib>HATANAKA TOSHIHIRO</creatorcontrib><creatorcontrib>OSUMI KOJI</creatorcontrib><title>ACYLSULFONAMIDE DERIVATIVE</title><description>PROBLEM TO BE SOLVED: To provide an ACC (acetyl-CoA carboxylase) activity inhibitor effective for treatment of hyperlipemia induced by obesity and fatness, abnormal glucose tolerance, diabetes, diabetic complications, hypertension and arteriosclerosis considered to be based on fatty liver and insulin tolerance. SOLUTION: An acylsulfonamide derivative represented by general formula (1), its analogue or its pharmaceutically acceptable salt has effective inhibitory actions on the ACC activity. COPYRIGHT: (C)2005,JPO&NCIPI</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBydI70CQ71cfP3c_T1dHFVcHEN8gxzDPEMc-VhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGBqaGZkZmhkaOxkQpAgCG3CDa</recordid><startdate>20050623</startdate><enddate>20050623</enddate><creator>MAEZONO KATSUMI</creator><creator>KONDO NOBUO</creator><creator>NIHEI YUKIO</creator><creator>SUZUKI NOBUYASU</creator><creator>ICHINOSE HIDEHIRO</creator><creator>YAMAMOTO TAKASHI</creator><creator>NAKANISHI EIJI</creator><creator>HATANAKA TOSHIHIRO</creator><creator>OSUMI KOJI</creator><scope>EVB</scope></search><sort><creationdate>20050623</creationdate><title>ACYLSULFONAMIDE DERIVATIVE</title><author>MAEZONO KATSUMI ; KONDO NOBUO ; NIHEI YUKIO ; SUZUKI NOBUYASU ; ICHINOSE HIDEHIRO ; YAMAMOTO TAKASHI ; NAKANISHI EIJI ; HATANAKA TOSHIHIRO ; OSUMI KOJI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2005162612A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MAEZONO KATSUMI</creatorcontrib><creatorcontrib>KONDO NOBUO</creatorcontrib><creatorcontrib>NIHEI YUKIO</creatorcontrib><creatorcontrib>SUZUKI NOBUYASU</creatorcontrib><creatorcontrib>ICHINOSE HIDEHIRO</creatorcontrib><creatorcontrib>YAMAMOTO TAKASHI</creatorcontrib><creatorcontrib>NAKANISHI EIJI</creatorcontrib><creatorcontrib>HATANAKA TOSHIHIRO</creatorcontrib><creatorcontrib>OSUMI KOJI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MAEZONO KATSUMI</au><au>KONDO NOBUO</au><au>NIHEI YUKIO</au><au>SUZUKI NOBUYASU</au><au>ICHINOSE HIDEHIRO</au><au>YAMAMOTO TAKASHI</au><au>NAKANISHI EIJI</au><au>HATANAKA TOSHIHIRO</au><au>OSUMI KOJI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ACYLSULFONAMIDE DERIVATIVE</title><date>2005-06-23</date><risdate>2005</risdate><abstract>PROBLEM TO BE SOLVED: To provide an ACC (acetyl-CoA carboxylase) activity inhibitor effective for treatment of hyperlipemia induced by obesity and fatness, abnormal glucose tolerance, diabetes, diabetic complications, hypertension and arteriosclerosis considered to be based on fatty liver and insulin tolerance. SOLUTION: An acylsulfonamide derivative represented by general formula (1), its analogue or its pharmaceutically acceptable salt has effective inhibitory actions on the ACC activity. COPYRIGHT: (C)2005,JPO&NCIPI</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JP2005162612A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ACYLSULFONAMIDE DERIVATIVE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A31%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MAEZONO%20KATSUMI&rft.date=2005-06-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2005162612A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |